✦ LIBER ✦

P278 Aspects that determine patient satisfaction in the management of mild to moderate ulcerative colitis: a Delphi study of patients and physicians

✍ Scribed by Casellas, F.; Ginard, D.; Riestra, S.; Blasco, A.J.; Lazaro, P.

Book ID: 122152526
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 66 KB
Volume: 8
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(14)60399-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P175 Patients' perceptions, attitudes, a

P175 Patients' perceptions, attitudes, and experiences about the management of mild-to-moderate ulcerative colitis

✍ Casellas, F.; Ginard, D.; Riestra, S.; Alfaro, N. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 63 KB

A comparison of physician-rated disease

A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis

✍ Chris D. Poole; Mark P. Connolly; Sandy Kildegaard Nielsen; Craig J. Currie; Phi 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 229 KB

P078 ERYTHROCYTES-MEDIATED DELIVERY OF D

P078 ERYTHROCYTES-MEDIATED DELIVERY OF DEXAMETHASONE IN PATIENTS WITH MILD TO MODERATE ULCERATIVE COLITIS REFRACTORY TO MESALAMINE. A RANDOMISED-CONTROLLED STUDY

✍ F. Bossa; A. Latiano; L. Rossi; M. Magnani; E. De Santo; O. Palmieri; T. Latiano 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 63 KB

P360 Symptom resolution and clinical rem

P360 Symptom resolution and clinical remission in patients with mild-to-moderate ulcerative colitis: analysis of the PODIUM trial

✍ Dignass, A.; Bokemeyer, B.; Mross, M.; Oudkerk Pool, M. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 67 KB

Sa1219 Efficacy of Budesonide MMx® in Re

Sa1219 Efficacy of Budesonide MMx® in Reduction of Symptoms in Patients With Mild-to-Moderately Active Ulcerative Colitis: A Pooled Analysis of the CORE I and CORE II Studies

✍ Sandborn, William; Hardiman, Yun; Huang, Michael; Harris-Collazo, Raul; Ballard, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 587 KB

Safety and tolerability of a modified fi

Safety and tolerability of a modified filter-type device for leukocytapheresis using ACD-A as anticoagulant in patients with mild to moderately active ulcerative colitis. Results of a pilot study

✍ Vladislaw Muratov; Joachim Lundahl; Aleksandra Mandic-Havelka; Kerstin Elvin; Åk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Cellsorba™ is a medical device for leukocytapheresis (LCAP) treatment of ulcerative colitis (UC). Cellsorba™ EX Global type has been developed from Cellsorba E for intended use with ACD‐A as anticoagulant. We evaluated safety and efficacy of the modified Cellsorba using ACD‐A in a pilot